Related Experiment Videos
[Extrapyramidal side-effects: avoidance, diagnosis and treatment]
W Wolfgang Fleischhacker1, Christian Widschwendter
1Abteilung für Biologische Psychiatrie Universitätsklinik für Psychiatrie Innsbruck, Medizinische Universität Innsbruck. wolfgang.fleischhacker@uibk.ac.at
Psychiatrische Praxis
|April 9, 2005
Summary
Newer antipsychotics reduce the risk of acute extrapyramidal side-effects (EPS), improving patient quality of life. This review covers EPS types, avoidance strategies, and diagnostic challenges, noting conflicting study results.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Medicine
Context:
- Antipsychotic medications are widely prescribed for psychiatric disorders.
- Extrapyramidal side-effects (EPS) are a significant concern with antipsychotic treatment, impacting patient adherence and quality of life.
- Newer antipsychotic agents are often associated with a lower incidence of EPS compared to older drugs.
Purpose:
- To provide a comprehensive overview of acute extrapyramidal side-effects (EPS) associated with antipsychotic treatment.
- To discuss the different clinical presentations and diagnostic challenges of EPS.
- To outline strategies for preventing and managing EPS, with a focus on newer antipsychotic medications.
Summary:
- Acute extrapyramidal side-effects (EPS) are common adverse events in antipsychotic therapy, significantly diminishing patient well-being and treatment compliance.
- While newer generation antipsychotics generally demonstrate a reduced risk of EPS compared to conventional agents, some studies present conflicting findings.
- This review examines the various forms of EPS, explores preventative measures, and addresses diagnostic and therapeutic complexities, including methodological issues in evaluating antipsychotic side effects.
Impact:
- Improved understanding of EPS can lead to better patient management and treatment adherence.
- Identifying the reduced risk of EPS with newer antipsychotics aids in optimizing pharmacotherapy for psychiatric conditions.
- Addressing methodological challenges in side-effect evaluation will enhance the reliability of future research on antipsychotic efficacy and safety.